Insurance coverage for physical ailments has expanded steadily, while coverage for mental health issues remains out of step ...

US-based biotechnology company Mind Medicine (MindMed) has dosed the first subject in the 52-week Phase III Voyage study of ...

Research reveals new connections between the gut and brain, suggesting more targeted depression and anxiety treatments, and a ...

MindMed has announced the dosing of the first patient in its phase 3 Voyage study of MM120 ODT, a pharmaceutically optimised form of lysergide D-tartrate (LSD) for treating Generalised Anxiety ...

Huntsman Mental Health Institute's Youth Residential Treatment program helped Jenna, a high school student facing depression ...

Anxiety rash is a stress-induced skin reaction, causing redness and itching. Know the causes, symptoms and tips on managing ...

Specific hypnotic techniques with the aid of subconscious resources can help patients improve or resolve their emetophobia ...

For the first time ever, researchers are administering LSD to patients in a Phase 3 clinical trial. The new study focuses on whether the psychedelic can be used to effectively treat generalized ...

In past trials, ketamine intravenous treatment has shown promise, with 64% of depression patients in trials experiencing ...

The findings showed that CBD did not significantly change scan-related anxiety when compared to a placebo, but researchers did find that CBD was safe and resulted in significantly lower overall ...

Focusing treatments for depression and anxiety to gut cells instead of brain cells may help people feel better without side effects.